Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Chubak"


11 mentions found


A Wolfe Research analyst raised his view on troubled bank stock Wells Fargo, reasoning that regulatory and interest rate risks both are priced into the stock. However, analysts at Oppenheimer lowered their views on high-flying tech stock Microsoft on fears that OpenAI losses could hamper performance. Delta's stock price has gained nearly 23% this year, but is in the red for the quarter. Chubak sees downside to consensus 2026 earnings across the board for the group — but that the risk is better captured in the current valuation of major banks including Wells Fargo. WFC YTD line Wells Fargo stock performance Chubak upgraded Wells Fargo to outperform from peer perform and kept his $65 price target on the stock, which implies 13.7% potential upside.
Persons: Wolfe, Bernstein, Oppenheimer, Bernstein Bernstein, David Vernon, Vernon, — Pia Singh, Timothy Horan, Horan, Lance Wilkes, Wilkes, Steven Chubak, Wells Fargo, Chubak Organizations: CNBC, Humana, Microsoft, Southwest Airlines, STARS, Wolfe Research, WFC Locations: Wells, Delta, Vernon, Atlanta, Wells Fargo
UBS raised its price target on Nvidia , calling for nearly 20% upside. He also set a price target of $640, which implies downside of 21%. — Lisa Kailai Han 5:50 a.m.: UBS hikes Nvidia price target, now sees 19% upside UBS sees more gains ahead for Nvidia . Analyst Timothy Arcuri raised his price target for the graphics processing unit manufacturer to $150 from $120. "Our recent supply chain checks confirm our prior suspicions that demand momentum for Blackwell rack-scale systems remains exceedingly robust," the analyst wrote.
Persons: Wolfe, JPMorgan Chase, Guggenheim, ServiceNow, John DiFucci, Lisa Kailai Han, Erika Najarian, — Lisa Kailai Han, Timothy Arcuri, Arcuri, Blackwell, Steven Chubak, Chubak, JPM, — Fred Imbert Organizations: CNBC, UBS, Nvidia, Wolfe Research, JPMorgan, Guggenheim, PNC, PNC Financial Services, JPMorgan Chase JPMorgan, JPMorgan Chase, P Bank ETF Locations: Friday's, 2H24
(This is CNBC Pro's live coverage of Tuesday's analyst calls and Wall Street chatter. Stifel opened coverage on Tesla with a buy rating and an ambitious price target as it sees multiple growth opportunities for the company. Crockett also increased his price target by $64 to $260, which now suggests shares can rally 24.4% from Tuesday's closing price. Goldman also hiked his price target by $7 to $52, now reflecting upside potential of 17.7% over Tuesday's close. Analyst Stephen Gengaro initiated the electric vehicle maker at a buy rating with a $265 price target.
Persons: Rosenblatt, Barton Crockett, Crockett, — Alex Harring, Atif Malik, Malik, Blackwell, Wolfe, Robinhood, Steven Chubak, Chubak, Jason Warnick, That's, Keith Gill, Katja Jancic, Jancic, Brian Ossenbeck, Ossenbeck, Campbell, Ken Goldman, hasn't, Goldman, underperformance, Stifel, Stephen Gengaro, Gengaro, Alex Harring Organizations: CNBC, Federal Express, JPMorgan, FedEx, Apple, Apple Intelligence, Android, Meta, Microsoft, Nvidia, Citi, Wolfe Research, . Steel, BMO Capital Markets, U.S, Steel, Nippon Steel, Nippon, US, U.S . Steel, CPB, Tesla Locations: Tuesday's, Japan, U.S
Netflix and a popular beauty stock were featured among Friday's biggest analyst calls. Analyst Rob Sanderson initiated coverage of DoorDash with a buy rating and $170 price target, citing strong execution. Alongside the upgrade, Blum downgraded Sunnova Energy to an equal weight rating and slashed his price target to $6 from $11, citing a higher-for-longer rate environment. "Share gains upmarket by Shopify support confidence in the durability of growth against tempered consumer spending expectations," wrote analyst Keith Weiss. The stock has tumbled 11% this year, but could rally 22% based on the firm's adjusted $85 price target.
Persons: Canaccord Genuity, Rob Sanderson, DoorDash, Sanderson, – Samantha Subin, Wolfe, Steven Chubak, BAC's, Chubak, bode, Wells, Michael Blum, Blum, Biden, Samantha Subin, Morgan Stanley, Keith Weiss, Weiss, — Samantha Subin, Canaccord, Maria Ripps, Steven Cahall, Price, Doug Anmuth, Morgan Stanley's Benjamin Swinburne, Jefferies, Ashley Helgans, Helgans, Fred Imbert Organizations: CNBC, Netflix, Friday's, Jefferies, Capital, Industry, Wolfe Research, Bank of America, of America, SCHW, Sunnova Energy, NOVA, Ulta Locations: Wells Fargo, China, Thursday's, Canada
Opinion | The Language of Gender Identity
  + stars: | 2024-04-17 | by ( ) www.nytimes.com   time to read: +1 min
To the Editor:Re “The Problem With Saying ‘Sex Assigned at Birth,’” by Alex Byrne and Carole K. Hooven (Opinion guest essay, nytimes.com, April 3):Mr. Byrne and Ms. Hooven argue that use of “assigned sex” terminology “creates doubt about a biological fact when there shouldn’t be any.” But sex characteristics are not “a biological fact”; they are rather a series of facts — anatomical, hormonal and genetic — that are not always in alignment. The term “sex assignment” derives from the medical literature of the 1940s and 1950s, in which physicians grappled with what was then called “hermaphroditism” and is now called “intersex” or “D.S.D.,” for disorders or differences of sex development. To conclude that the words “assigned at birth” are needless is to deny the complexity of biological sex and to erase both the history of intersex conditions and the embodied reality of the people who are born and live with them. Barbara M. ChubakNew YorkThe writer is an associate professor of urology at the Icahn School of Medicine at Mount Sinai.
Persons: Alex Byrne, Carole K, Byrne, Hooven, Barbara M, Chubak Organizations: Icahn School of Medicine Locations: York, Mount Sinai
Watch CNBC's full interview with Wolfe's Steven Chubak
  + stars: | 2023-06-30 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWatch CNBC's full interview with Wolfe's Steven ChubakSteven Chubak, Wolfe Research, joins CNBC's Leslie Picker and Mike Santoli on 'Closing Bell Overtime' to talk breaking news concerning bank capital allocation plans.
Persons: Wolfe's Steven Chubak Steven Chubak, Wolfe, Leslie Picker, Mike Santoli Organizations: Wolfe Research
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email'Commitment to the buyback is being viewed constructively' at Morgan Stanley: Wolfe's Steven ChubakSteven Chubak, Wolfe Research, joins CNBC's Leslie Picker and Mike Santoli on 'Closing Bell Overtime' to talk breaking news concerning bank capital allocation plans.
Persons: Morgan Stanley, Wolfe's Steven Chubak Steven Chubak, Wolfe, Leslie Picker, Mike Santoli Organizations: Wolfe Research
Morgan Stanley netted $109.6 billion in new client assets in the first quarter of 2023. Before the hiring binge, Morgan Stanley and other banks gave a $30 billion lifeline to First Republic. Morgan Stanley beat profit estimates with its first-quarter results and got a little boost from the banking crisis. Analyst Steven Chubak of Wolfe Research asked how First Republic advisors flocking to Morgan Stanley had boosted quarterly inflows. That leaves $19.6 billion attributable to advisors and clients fleeing struggling banks like First Republic for Morgan Stanley, a too-big-to-fail institution.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWatch CNBC’s full interview with Wolfe Research's Steven ChubakSteven Chubak, Wolfe Research managing director, joins 'Squawk on the Street' to discuss the unease lingering in banks.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailRisk is growing in the broader financial sector, says Wolfe Research's Steven ChubakSteven Chubak, Wolfe Research managing director, joins 'Squawk on the Street' to discuss the unease lingering in banks.
There's "less compelling" upside for Goldman Sachs in 2023, according to Wolfe Research. The stock has done very well in that time (+72%), outperforming the S & P (+36%) and BKX (+8%)," Chubak wrote in a Wednesday note. "However, as we head in 2023, we see less compelling upside in shares, prompting us to move to the sidelines," Chubak wrote. Shares of Goldman Sachs declined 10% in 2022, outperforming the S & P 500, which was down about 19% in the same period. Shares of Goldman Sachs rose slightly in Wednesday premarket trading.
Total: 11